Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium
- PMID: 39141569
- PMCID: PMC11531093
- DOI: 10.1164/rccm.202402-0374SO
Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium
Abstract
Post-tuberculosis (post-TB) lung disease is increasingly recognized as a major contributor to the global burden of chronic lung disease, with recent estimates indicating that over half of TB survivors have impaired lung function after successful completion of TB treatment. However, the pathologic mechanisms that contribute to post-TB lung disease are not well understood, thus limiting the development of therapeutic interventions to improve long-term outcomes after TB. This report summarizes the work of the Pathogenesis and Risk Factors Committee for the Second International Post-Tuberculosis Symposium, which took place in Stellenbosch, South Africa, in April 2023. The committee first identified six areas with high translational potential: 1) tissue matrix destruction, including the role of matrix metalloproteinase dysregulation and neutrophil activity; 2) fibroblasts and profibrotic activity; 3) granuloma fate and cell death pathways; 4) mycobacterial factors, including pathogen burden; 5) animal models; and 6) the impact of key clinical risk factors, including HIV, diabetes, smoking, malnutrition, and alcohol. We share the key findings from a literature review of those areas, highlighting knowledge gaps and areas where further research is needed.
Keywords: fibrosis; matrix metalloproteinases; neutrophils; post-tuberculosis lung disease; tuberculosis.
References
-
- World Health Organization. Global tuberculosis report 2022. Geneva, Switzerland: World Health Organization; 2022.
-
- Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis . 2019;19:1129–1137. - PubMed
-
- Dodd PJ, Yuen CM, Jayasooriya SM, van der Zalm MM, Seddon JA. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis . 2021;21:984–992. - PubMed
Publication types
MeSH terms
Grants and funding
- GNT2020750/Australia National Health and Medical Research Council/United States
- 01KA2223B/German Federal Ministry of Education and Research/United States
- R01AI166988/National Institute of Allergy and Infectious Diseases/United States
- R21 AI146813/AI/NIAID NIH HHS/United States
- R37AI167750/National Institute of Allergy and Infectious Diseases/United States
- R01 AI166988/AI/NIAID NIH HHS/United States
- P30 AI168386/AI/NIAID NIH HHS/United States
- R21AI146813/National Institute of Allergy and Infectious Diseases/United States
- Research Networks for Health Innovations in Sub-Saharan Africa (RHISSA) TB-SEQUEL Network/United States
- R33 AI138280/AI/NIAID NIH HHS/United States
- R33AI138280/National Institute of Allergy and Infectious Diseases/United States
- R37 AI167750/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous